← Back to Clinical Trials
Recruiting Phase 4 NCT07271420

NCT07271420 Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07271420
Status Recruiting
Phase Phase 4
Sponsor Chinese University of Hong Kong
Condition Hypertension
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2020-01-01
Primary Completion 2026-12-31

Trial Parameters

Condition Hypertension
Sponsor Chinese University of Hong Kong
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 40
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2020-01-01
Completion 2026-12-31
Interventions
Hydrochlorothiazide 25mg once per day

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis

Eligibility Criteria

Inclusion Criteria: * Patients on chronic peritoneal dialysis, with uncontrolled hypertension (SBP \>140 mmHg and/or DBP \>90 mmHg) Exclusion Criteria: * Patients with a life expectancy of less than 3 months, planned conversion to hemodialysis, or scheduled kidney transplantation within 3 months

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE HYPERTENSION TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology